COUMARIN (ESCULETIN) - AN ANTIRHEUMATOID ARTHRITIC COMPOUND: AN UPDATE
DOI:
https://doi.org/10.22159/ajpcr.2018.v11s4.31710Keywords:
Coumarin, Esculetin, Rheumatoid arthritis, Molecular mechanismAbstract
Context: Esculetin is a natural polyphenolic compound. It is chemically 6,7-dihydroxycoumarin and one of the ingredients of Cortex fraxini, a Chinese traditional medicine. It is used as a dietary supplement and found as non-toxic. Recently, there are many research works evaluated on esculetin in arthritis with supported molecular mechanisms.
Objectives: Esculetin becoming more attractive prodrug for arthritis. Hence, the present minireview will consolidate the targeted site of esculetin in the treatment of arthritis over the past decade.
Results: The most important molecular mechanism of esculetin is an antioxidant activities with decreased level of reactive oxygen species/reactive nitrogen species. It also inhibited lipoxygenase 5, lipoxygenase 12, and tyrosinase enzymes. It reduces the inflammation by modulating the key inflammatory enzyme matrix metalloproteinase-1 activity. It also lowers the nitrous oxide and prostaglandin E2 level in synovial fluid. Esculetin derivatives such as 5-methoxy esculetin inhibited the activity of nitrogen-activated protein kinases. The updated data also reveal that esculetin suppresses the leukotriene B4 level in plasma of adjuvant-induced arthritis tested animals.
Conclusion: The presented update showed that esculetin may be useful as a tool in regulating the mechanism and physiological functions of the inflammatory mediators and enzyme. Hence, the presented review work may be considered as a scientific proof for the development of an attractive drug candidate for the patient with rheumatoid arthritis.
Downloads
References
Yang TM, Ge X, Wang XN. ???. Med J Natl Defending Forces Northwest China 2003;24:387.
Weng YC, Liu JW, Cui C, Zhao QC. Isolation and identification of the constituents from fraxini cortex and their in vitro antibacterial activity. Chin J Med Chem 2014;1:40-7.
Liu SQ, He L, Peng H, Liu J. Effect of ash bark on matrix metalloproteinase 1, nitricoxide and prostaglandin E2 in rabbits with experimental osteoarthritis. Chin J Clin Rehabil 2005;9:150-3.
Przemyslaw R, Emilia G, Slawomir M, Bujalskazadrozny M. Antinociceptive properties of esculetin in non-inflammatory and inflammatory models of pain in rats. Clin Exp Pharmacol Physiol 2015;42:213-9.
Kaneko T, Tahara S, Takabayashi F. Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2-dimethylhydrazine in rat colons. Biol Pharm Bull 2007;30:2052-7.
Marinova EM, Yanishlieva NV, Kostova IN. Antioxidative action of the ethanolic extract and some hydroxycoumarins of Fraxinus ornus bark. Food Chem 1994;51:125-32.
Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 2007;53:724-32.
Shabanov PD, Vislobokov AI. Neuronoprotective action of cortexin andcortagen. Rev Clin Pharmacol Drug Ther 2013;11:17.
Pan YM. Antioxidant activity of ethanolic extract of cortex fraxini and use in peanut oil. Food Chem 2007;103:913-8.
Issa YM, El-Hawary WF, Moustafa ME, Refaat M. ChemInform abstract: Spectroscopic studies on some new azo dyes derived from 4-methylesculetin and their biological activity. J Indian Chem Soc 1997;74:777-80.
Liang C, Ju W, Pei S, Tang Y, Xiao Y. Pharmacological activities and synthesis of esculetin and its derivatives: A mini-review. Molecules 2017;22:E387.
Duan HQ, Zhang YD, Fan K, Suo ZW, Hu G, Mu X. Anti-inflammatory mechanism of esculetin. Chin J Vet Med 2007;43:45-6.
Wang ZQ, Xia Y. Protective effect of esculetin on acute myocardial ischemia reperfusion injury in rats. J Chengdu Med Coll 2011;6:49-51.
Rubio V, Calviño E, GarcÃa-Pérez A, Herráez A, Diez JC. Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism. Chem Biol Interact 2014;220:129-39.
Chu CY, Tsai YY, Wang CJ, Lin WL, Tseng TH. Induction of apoptosis by esculetin in human leukemia cells. Eur J Pharmacol 2001;416:25-32.
Gilani AH, Janbaz KH, Shah BH. Esculetin prevents liver damage induced by paracetamol and CCL4. Pharmacol Res 1998;37:31-5.
Prabakaran D, Ashokkumar N. Protective effect of esculetin on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of experimental diabetic rats. Biochimie 2013;95:366-73.
Duncan SH, Leitch EC, Stanley KN, Richardson AJ, Laven RA, Flint HJ, et al. Effects of esculin and esculetin on the survival of Escherichia coli O157 in human faecal slurries, continuous-flow simulations of the rumen and colon and in calves. Br J Nutr 2004;91:749-55.
Liang M. Isolation and activity of antioxidant ingredients in cortex fraxini. Sci Technol Food Ind 2006;27:64-6.
Dai R, Zheng QL, XU QS, Zhu W. ???. Acta Med Univ Sci Technol Huazhong 2009;38:239-42.
Yang JY, Della-Fera MA, Baile CA. Esculetin induces mitochondria-mediated apoptosis in 3T3-L1 adipocytes. Apoptosis 2006;11:1371-8.
Kim Y, Lee J. Esculetin, a coumarin derivative, suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes. J Funct Foods 2015;12:509-15.
Kim Y, Park Y, Namkoong S, Lee J. Esculetin inhibits the inflammatory response by inducing heme oxygenase-1 in cocultured macrophages and adipocytes. Food Funct 2014;5:2371-7.
Katta S, Karnewar S, Panuganti D, Jerald MK, Sastry BK, Kotamraju S, et al. Mitochondria-targeted esculetin inhibits PAI-1 levels by modulating STAT3 activation and miR-19b via SIRT3: Role in acute coronary artery syndrome. J Cell Physiol 2018;233:214-25.
Park S, Moon K, Park CS, Jung DH, Cha J. Synthesis of aesculetin and aesculin glycosides using engineered Escherichia coli expressing Neisseria polysaccharea amylosucrase. J Microbiol Biotechnol 2018;28:566-70.
Kim Y, Lee J. Esculetin inhibits adipogenesis and increases antioxidant activity during adipocyte differentiation in 3T3-L1 cells. Prev Nutr Food Sci 2017;22:118-23.
Zhu L, Nang C, Luo F, Pan H, Zhang K, Liu J, et al. Esculetin attenuates lipopolysaccharide (LPS)-induced neuroinflammatory processes and depressive-like behavior in mice. Physiol Behav 2016;163:184-92.
Sulakhiya K, Keshavlal GP, Bezbaruah BB, Dwivedi S, Gurjar SS, Munde N, et al. Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neurosci Lett 2016;611:106-11.
Maoa G, Zhanga S, Songa H, Dinga S, Zhua P, Wangb X, et al. Synthesis, biological activities and therapeutic properties of esculetin and its derivatives. J Chem Pharm Res 2015;7:122-30.
Wu L, Li X, Wu H, Long W, Jiang X, Shen T, et al. 5-methoxyl aesculetin abrogates lipopolysaccharide-induced inflammation by suppressing MAPK and AP-1 pathways in RAW 264.7 cells. Int J Mol Sci 2016;17:315.
Chen T, Guo Q, Wang H, Zhang H, Wang C, Zhang P, et al. Effects of esculetin on lipopolysaccharide (LPS)-induced acute lung injury via regulation of rhoA/Rho kinase/NF-кB pathways in vivo and in vitro. Free Radic Res 2015;49:1459-68.
Lee SJ, Lee US, Kim WJ, Moon SK. Inhibitory effect of esculetin on migration, invasion and matrix metalloproteinase-9 expression in TNF- α-induced vascular smooth muscle cells. Mol Med Rep 2011;4:337-41.
Silván AM, Abad MJ, Bermejo P, Sollhuber M, Villar A. Antiinflammatory activity of coumarins from Santolina oblongifolia. J Nat Prod 1996;59:1183-5.
Loggix RP. Studied anti-inflammatory action of bazopyrones by inhibition of cyclo and lipo oxygenase using croton oil ear test in mice. 1988.
Tubaro A, Del Negro P, Ragazzi E, Zampiron S, Della Loggia R. Anti-inflammatory and peripheral analgesic activity of esculetin in vivo. Pharmacol Res Commun 1988;20 Suppl 5:83-5.
Liu SQ, He L, Peng H. Effect of esculetin on osteoarthritis in rabbit. Med J Wuhan Univ 2004;9:567-70.
Lin HC, Tsai SH, Chen CS, Chang YC, Lee CM, Lai ZY, et al. Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities. Biochem Pharmacol 2008;75:1416-25.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
